Double-blind, Randomized, Placebo-controlled Two-period Crossover Study to Assess the Effect of Levocarnitine on Vismodegib-associated Muscle Spasms
This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- dietary supplement : levocarnitine
- other : questionnaire administration
- other : placebo
Ages Eligible For Study:
- Taking vismodegib daily - Subject answers item #1 of muscle spasms questionnaire as moderate or severe intensity at time of screening - At least one muscle spasm per day at time of screening - Muscle spasms onset after starting vismodegib - Willing and able to understand and sign consent form